Balchem Corporation

NasdaqGS:BCPC 株式レポート

時価総額：US$5.2b

Balchem マネジメント

マネジメント 基準チェック /44

Balchemの CEO はTed Harrisで、 Apr2015年に任命され、 の在任期間は 11.08年です。 の年間総報酬は$ 7.89Mで、 15.2%給与と84.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.29%を直接所有しており、その価値は$ 15.35M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と8.3年です。

主要情報

Ted Harris

最高経営責任者

US$7.9m

報酬総額

CEO給与比率15.18%
CEO在任期間11.1yrs
CEOの所有権0.3%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間8.3yrs

経営陣の近況

Recent updates

Balchem: An Attractive Valuation Makes This Stock A Buy

Mar 27

Long-Term Nutrition And Health Trends Will Support Stronger Margins And Earnings Potential

Catalysts About Balchem Balchem supplies specialty nutrients and ingredients for human, animal and plant health, along with performance gases and related solutions. What are the underlying business or industry changes driving this perspective?

Encapsulation Investments And International Expansion Will Shape Balanced Future For Nutrition Specialist

Catalysts About Balchem Balchem produces specialty nutrition and ingredient solutions for human, animal and plant health, along with performance gases. What are the underlying business or industry changes driving this perspective?

BCPC: Dividend Increase And Buyback Program Will Support Steady Future Returns

Analysts kept their Balchem fair value estimate broadly steady at $191, pointing to only very small tweaks in assumptions such as discount rate, long term revenue growth, profit margin and future P/E as the basis for maintaining their target level. What's in the News On December 9, 2025, Balchem Corporation's Board of Directors declared an annual dividend of $0.96 per share, payable on January 20, 2026, to stockholders of record as of December 23, 2025.

If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

Feb 15
If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

BCPC: Share Repurchases And Higher Dividend Will Support Attractive Future Returns

Analysts have maintained their fair value estimate for Balchem at US$191. They have made only minimal adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions, indicating that their overall view on the stock's valuation drivers remains essentially unchanged.

Is Now An Opportune Moment To Examine Balchem Corporation (NASDAQ:BCPC)?

Feb 01
Is Now An Opportune Moment To Examine Balchem Corporation (NASDAQ:BCPC)?

BCPC: Share Repurchases And Rising Dividend Will Support Attractive Future Returns

Analysts have maintained their Balchem fair value estimate at US$191, with only small tweaks to the discount rate, revenue growth, profit margin, and forward P/E assumptions. This reflects a largely unchanged view on the stock's risk and earnings profile.

BCPC: Share Repurchases And Dividend Increases Will Support Attractive Future Returns

Analysts kept their fair value estimate for Balchem steady at US$191, pointing to only very small model tweaks in the discount rate, revenue growth, margin and forward P/E assumptions rather than any change in their overall view of the company. What's in the News Balchem Corporation announced a share repurchase program authorizing the company to buy back up to 4,000,000 shares, with no expiration date on the program (Key Developments).

BCPC: Share Repurchases And Dividend Increases Will Drive Attractive Future Returns

Analysts have maintained their price target on Balchem at approximately $191.00. This reflects only marginal tweaks to underlying assumptions such as discount rate, revenue growth, and profit margin, rather than a material change in their outlook.

BCPC: Share Repurchases Will Support Attractive Long Term Return Potential

Analysts have lowered their price target on Balchem by approximately $9 to about $191 per share, reflecting more cautious assumptions around revenue growth and profit margins, even though long term valuation multiples are slightly higher. What's in the News Completed a long running share repurchase program, buying back a total of 3,475,622 shares, or about 12.76% of shares outstanding, for approximately $190.58 million since the authorization began in 1999 (Key Developments) During the most recent quarter from July 1, 2025 to September 30, 2025, repurchased 95,760 shares, roughly 0.3% of shares outstanding, for $15.42 million as the final tranche under the existing buyback plan (Key Developments) Valuation Changes The Fair Value Estimate has fallen modestly from about $200.33 to $191.00 per share, reflecting a slightly more conservative outlook.

Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital

Dec 01
Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital

Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Oct 10
Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Sep 26
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 26
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

Jul 21
Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Jun 23
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

May 26
When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem's Q3 Shows Record Earnings And Valuation Pressure

Oct 28
User avatar

Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion

Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.

Balchem: A Tale Of Two Businesses

May 10

Balchem: Potential Turnaround Is In The Price

Feb 21

CEO報酬分析

Balchem の収益と比較して、Ted Harris の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2026n/an/a

US$158m

Dec 31 2025US$8mUS$1m

US$155m

Sep 30 2025n/an/a

US$149m

Jun 30 2025n/an/a

US$143m

Mar 31 2025n/an/a

US$137m

Dec 31 2024US$7mUS$1m

US$128m

Sep 30 2024n/an/a

US$122m

Jun 30 2024n/an/a

US$117m

Mar 31 2024n/an/a

US$115m

Dec 31 2023US$6mUS$1m

US$109m

Sep 30 2023n/an/a

US$103m

Jun 30 2023n/an/a

US$99m

Mar 31 2023n/an/a

US$99m

Dec 31 2022US$12mUS$1m

US$105m

Sep 30 2022n/an/a

US$109m

Jun 30 2022n/an/a

US$109m

Mar 31 2022n/an/a

US$102m

Dec 31 2021US$6mUS$1m

US$96m

Sep 30 2021n/an/a

US$93m

Jun 30 2021n/an/a

US$90m

Mar 31 2021n/an/a

US$88m

Dec 31 2020US$5mUS$1m

US$85m

Sep 30 2020n/an/a

US$83m

Jun 30 2020n/an/a

US$82m

Mar 31 2020n/an/a

US$81m

Dec 31 2019US$4mUS$915k

US$80m

報酬と市場: Tedの 総報酬 ($USD 7.89M ) は、 US市場 ($USD 8.55M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Tedの報酬は、過去 1 年間の会社の業績と一致しています。

CEO

Ted Harris (60 yo)

11.1yrs
在職期間
US$7,894,874
報酬

Mr. Theodore Lee Harris, also known as Ted, has been the Chief Executive Officer and President at Balchem Corporation since April 28, 2015. He serves as an Independent Director of Pentair Plc since April 3...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Theodore Harris
CEO, President & Chairman11.1yrsUS$7.89m0.29%
$ 15.4m
Carl Bengtsson
Executive VP7.3yrsUS$2.97m0.091%
$ 4.7m
Hatsuki Miyata
Executive VP3.8yrsUS$2.39m0.016%
$ 810.4k
M. Tignor
Senior VP & Chief Human Resources Officer4.3yrsUS$1.78m0.038%
$ 2.0m
Frederic Boned
Senior VP3.5yrsUS$2.25m0.012%
$ 647.9k
Erin Gilson
VP & Chief Accounting Officerless than a yearデータなし0.0078%
$ 404.2k
Martin Reid
Senior VP & Chief Supply Chain Officer5.3yrsUS$1.49m0.025%
$ 1.3m
Job L. Gunsteren
Senior VP & GM of Specialty Products3.7yrsデータなしデータなし
George Graham
Senior VP and Chief R&D Officerless than a yearデータなし0.010%
$ 523.4k
3.8yrs
平均在職期間
48.5yo
平均年齢

経験豊富な経営陣: BCPCの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Theodore Harris
CEO, President & Chairman11.1yrsUS$7.89m0.29%
$ 15.4m
Daniel Knutson
Independent Director8.3yrsUS$251.00k0.014%
$ 733.3k
David Fischer
Independent Director15.7yrsUS$231.00k0.028%
$ 1.4m
Matthew Wineinger
Lead Independent Director10.7yrsUS$271.00k0.025%
$ 1.3m
Olivier Rigaud
Independent Director2.7yrsUS$231.00k0.0075%
$ 388.5k
Kathleen Fish
Independent Director4.9yrsUS$246.00k0.011%
$ 557.8k
Monica Vicente
Independent Director2.7yrsUS$231.00k0.0075%
$ 388.5k
8.3yrs
平均在職期間
61yo
平均年齢

経験豊富なボード: BCPCの 取締役会 は 経験豊富 であると考えられます ( 8.3年の平均在任期間)。

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/05/05 14:20
終値2026/05/05 00:00
収益2026/03/31
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Balchem Corporation 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9

アナリスト機関
Robert LabickCJS Securities, Inc.
Timothy RameyD.A. Davidson & Co.
Raghuram SelvarajuH.C. Wainwright & Co.